Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,209 recruiting studies in this area right now.
By phase
- Not applicable9,535
- Phase 24,407
- Phase 12,674
- Phase 1/Phase 21,653
- Phase 31,394
- Phase 2/Phase 3285
- Phase 4261
Top conditions
- Breast Cancer1,201
- Prostate Cancer645
- Cancer634
- Colorectal Cancer480
- Lung Cancer418
- Ovarian Cancer338
- Multiple Myeloma329
- Pancreatic Cancer290
- Gastric Cancer283
- Acute Myeloid Leukemia280
- Hepatocellular Carcinoma256
- Solid Tumor247
- Advanced Solid Tumor233
- Head and Neck Cancer226
- Cervical Cancer225
- Endometrial Cancer210
- Advanced Solid Tumors203
- Esophageal Cancer190
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University302
- National Cancer Institute (NCI)293
- Memorial Sloan Kettering Cancer Center291
- Sun Yat-sen University274
- Mayo Clinic238
- City of Hope Medical Center145
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences142
- AstraZeneca133
- Second Affiliated Hospital, Zhejiang University, School of Medicine128
Where studies are running
- California1,414
- Texas635
- Arizona507
- Florida436
- Alabama430
- New York406
- Massachusetts340
- Maryland329
- New Jersey272
- Pennsylvania233
Recruiting studies20,209 total
- NCT07443306RecruitingPhase 2
Testing Flonoltinib for myelofibrosis after JAK inhibitor failure
This trial tests a new tablet, Flonoltinib, for people with medium-to-high risk myelofibrosis whose prior JAK inhibitor treatment stopped working, caused side effects, or wasn't tolerated. The goal is to see if this new drug can help reduce spleen size and improve symptoms.
Chengdu, SichuanAges 18–80 - NCT07444437RecruitingPhase 2
LM103 after surgery for lung cancer
This trial tests if LM103, given after surgery and standard chemotherapy, helps prevent non-small cell lung cancer from coming back. It is for people who have already had chemotherapy or immunotherapy before surgery and whose cancer did not return after surgery.
Guangzhou, GuangdongAges 18–75 - NCT07439653RecruitingPhase 1/Phase 2
Testing TORL-5-700 for advanced lymphoma
This trial tests a new treatment called TORL-5-700 for people with certain types of non-Hodgkin lymphoma that have not responded to other treatments. The goal is to see how safe it is and how well it works.
Fullerton, CaliforniaAges 18 years+ - NCT07439094RecruitingPhase 1/Phase 2
Study of a new drug (CKD-703) for advanced solid tumors and lung cancer
This trial tests a new drug called CKD-703 for people with advanced solid tumors, including a type of lung cancer (non-small cell lung cancer) that has a specific marker called c-Met. The study aims to see if the drug is safe and effective for those who have already tried other treatments that didn't work or caused side effects.
Ohio City, OhioAges 19 years+ - NCT07444281RecruitingPhase 1
CAR T-cell therapy for GPC3-positive advanced lung cancer
This trial tests a new type of immunotherapy called CAR T-cells (C-CAR031) for people with advanced squamous cell lung cancer that has a specific marker called GPC3. The treatment involves collecting your own immune cells, modifying them to attack cancer, and infusing them back into your body.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07441174RecruitingPhase 1/Phase 2
A study of two drugs for KRAS G12D tumors
This trial tests two experimental drugs (IN10018 and RNK08954) together for people with advanced solid tumors that have a specific KRAS G12D mutation. The goal is to see if this combination can shrink tumors when standard treatments have stopped working.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06807307Recruiting
Using genetic tests to predict immunotherapy response in lung cancer
This study looks at genetic material from tumor samples to find patterns that can predict whether immunotherapy will work for people with advanced non-small cell lung cancer (NSCLC). The goal is to improve how doctors choose treatments for each patient.
RomeAges 18 years+ - NCT06806462Recruiting
Biomarkers study for bone metastasis in cancer
This study collects samples to find biomarkers related to bone metastases in common cancers. It might help doctors better understand why cancer spreads to bones.
Bologna, BolognaAges 18 years+ - NCT06806917Recruiting
Study on lymph node surgery for testicular cancer over 20 years
This study reviews 20 years of experience in removing lymph nodes in the abdomen (RPLND) for testicular cancer. It aims to understand the outcomes of this surgery for people who had it after chemotherapy or for early-stage cancer.
Bologna, BolognaAges Any age - NCT05749900RecruitingPhase 1/Phase 2
First-line antibody, chemo, and immunotherapy for HER2 bile duct cancer
This trial studies a combination of trastuzumab (an antibody), gemcitabine and cisplatin (chemo), plus nivolumab (immunotherapy) as the first treatment for advanced HER2-positive biliary tract cancer. It may help shrink tumors and improve outcomes by targeting HER2 and boosting the immune system.
SeoulAges 19 years+ - NCT06806579Recruiting
Immunotherapy for advanced liver cancer
This trial studies how well immunotherapy drugs (atezolizumab and bevacizumab) work for people with advanced liver cancer that cannot be treated with local procedures. It looks at real-life results to see if these treatments help people live longer and feel better.
Torrette, ANAges 18 years+ - NCT06356012RecruitingPhase 4
Imiquimod for high-risk HPV cervical lesions
This trial tests if imiquimod cream can help clear high-grade cervical lesions caused by high-risk HPV. It may be an option for people who want to avoid surgery.
BarretosAges 25–45 - NCT07443514Recruiting
Thinking and memory in people with DLBCL
This study looks at how thinking and memory may be affected in people newly diagnosed with a type of lymphoma called diffuse large B-cell lymphoma (DLBCL) who are about to start a common chemotherapy regimen known as R-CHOP. It also includes a comparison group of healthy relatives. The goal is to understand how treatment may affect cognitive function over time.
LjubljanaAges 18 years+ - NCT07441733Recruiting
Using a green dye to map lymph nodes in breast cancer surgery
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
Peschiera del Garda, VeronaAges 18 years+ - NCT07443943RecruitingPhase 2
Potato starch supplement for joint pain from hormone therapy
This trial studies whether a dietary supplement made from resistant potato starch can help reduce joint and muscle pain in people who are about to start aromatase inhibitor therapy for breast cancer or high risk. You take the supplement daily and report how you feel over 24 weeks.
Ann Arbor, MichiganAges Any age - NCT07438106RecruitingPhase 2
HRS-4642 with chemo to shrink pancreatic cancer before surgery
This trial tests a new drug, HRS-4642, combined with a two-drug chemotherapy (nab-paclitaxel and gemcitabine) for people with locally advanced pancreatic cancer that has not spread. The goal is to shrink the tumor enough so it can be surgically removed.
NanjingAges 18–75 - NCT07436364RecruitingEarly Phase 1
Ultrasound to monitor sarcoma response to radiation
This trial uses contrast-enhanced ultrasound to see how well soft tissue sarcoma responds to radiation therapy given before surgery. The goal is to find out if this imaging method can help doctors assess treatment effects earlier.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07439458Recruiting
Exercise effects on tumor cells in breast cancer survivors
This trial tests whether different types and intensities of exercise can change tumor-related cells in survivors of triple-negative breast cancer. It may help understand how exercise could improve long-term outcomes.
Riga, Dzirciema Street 16Ages 35 years+ - NCT07444216Recruiting
A study on hope in teens and young adults with advanced cancer
This study explores hope in patients aged 12-25 with pediatric cancer that has returned, not responded to treatment, or has no cure. Participants take photos and share their stories to help doctors and families understand what hope means during early-phase clinical trials (phase 1 or 2).
Memphis, TennesseeAges 12 years+ - NCT07439211RecruitingPhase 1
Testing a new drug combo for acute myeloid leukemia
This trial tests a new drug, eganelisib, combined with azacitidine and venetoclax for patients with acute myeloid leukemia (AML). It's for people whose AML has come back or hasn't responded to treatment, or for those with a high-risk type who haven't been treated yet.
Boston, MassachusettsAges 18–90 - NCT07443618Recruiting
Measuring fluid buildup in cancer patients
This study tests a new way to measure fluid buildup (swelling) in cancer patients. It may help doctors better manage lymphedema after breast cancer radiation or swelling in the legs from chemotherapy.
Aalborg, The North Denmark RegionAges 18 years+ - NCT07441889RecruitingPhase 1/Phase 2
HER2-targeting immune cells for metastatic breast and prostate cancer
This trial tests a new treatment using specially designed immune cells that target HER2, a protein found on some cancer cells. It is for people with metastatic breast or prostate cancer that has worsened after prior treatments.
Charlottesville, VirginiaAges 18 years+ - NCT07443475RecruitingPhase 2
Electric field therapy for vulvar cancer that has come back
This trial tests whether a targeted electric current can improve treatment for vulvar cancer that has returned after standard therapy. The treatment uses electricity to help chemotherapy drugs enter cancer cells more effectively.
LjubljanaAges 18 years+ - NCT07439991Recruiting
Study of blood clot risks after lung cancer surgery
This study looks at why some people develop blood clots after lung cancer surgery. By tracking your recovery for 30 days, researchers hope to find better ways to predict and prevent clots in the future.
Changchun, JilinAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,209 recruiting oncology studies from the U.S. registry right now, out of 30,299 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.